BioCentury
ARTICLE | Product Development

Despite senior management shake-up, Novartis’ pipeline is primed to deliver

Why the executive exodus at Novartis likely won’t derail CEO Narasimhan’s growth plans

June 14, 2019 9:21 PM UTC

A string of departures at Novartis AG and strategic shifts by new CEO Vasant Narasimhan have produced a fairly thorough makeover of the executive committee he inherited in 2018. The team gains a pipeline that is stocked with first-in-class agents and potential blockbusters -- dealing the newcomers a strong hand as they settle in.

In the space of two weeks, Novartis lost one executive team member and two other leaders, bringing to four the top level departures this year...

BCIQ Company Profiles

Novartis AG